In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 392, Issue 3, 1997, Pages 211-222

  Walker, Vernon E ^a,b   Sisk, Susan C ^c   Upton, Patricia B ^d   Wong, Brian A ^c   Recio, Leslie ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b WADSWORTH CENTER   (United States)

^c CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Dose response; Ethylene oxide; Hprt; In vivo mutation; LacI; Transgenic mice

Indexed keywords

ALKYLATING AGENT; CONCANAVALIN A; ETHYLENE OXIDE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INTERLEUKIN 2; TIOGUANINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DOSE RESPONSE; GENE LOCUS; GENE MUTATION; MALE; MOUSE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENIC MOUSE;

ADMINISTRATION, INHALATION; ANIMALS; BACTERIAL PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI PROTEINS; ETHYLENE OXIDE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MALE; MICE; MICE, TRANSGENIC; MUTAGENICITY TESTS; MUTAGENS; REPRESSOR PROTEINS; SPLEEN; T-LYMPHOCYTES; THYMUS GLAND; TIME FACTORS;

ANIMALIA; MUS MUSCULUS;

EID: 0030744798     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(97)00062-4     Document Type: Article

References (40)

1. T.R. Skopek, V.E. Walker, J.E. Cochrane, T.R. Craft, N.F. Cariello, Mutational spectrum at the Hprt locus in splenic T cells of B6C3F1 mice exposed to N-ethyl-N-nitrosourea, Proc. Natl. Acad. Sci. USA 89 (1992) 7866-7870.
2. Sisk, S., L.J. Pluta, K.G. Meyer and L. Recio (1996) Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure, Mutation Res., submitted.
3. Environmental Protection Agency (EPA) (1990) Office of Health and Environmental Assessment, V.L. Dellarco (Ed.), U.S. EPA Genetic risk assessment on ethylene oxide, Environ. Mol. Mutagen., 16, 81-134.
4. V.E. Walker, T.R. Fennell, J.A. Boucheron, N. Fedtke, F. Ciroussel, J.A. Swenberg, Macromolecular adducts of ethylene oxide: a literature review and a time-course study on the formation of 7-(2-hydroxyethyl)guanine following exposures of rats by inhalation, Mutation Res. 233 (1990) 151-164.
5. International Agency for Research on Cancer (IARC) (1994) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Some Industrial Chemicals, Vol. 60., IARC Sci. Publ., Lyon.
6. W.M. Snellings, C.S. Weil, R.R. Maronpot, A two-year inhalation study of carcinogenic potential of ethylene oxide in Fischer 344 rats, Toxicol. Appl. Pharmacol. 75 (1984) 105-117.
7. National Toxicology Program (NTP), Department of Health and Human Services (1988) Toxicology and carcinogenesis studies of ethylene oxide in B6C3F1 mice (inhalation studies), NTP Technical Report, Vol. 326, USDHHS, U.S. Government Printing Office, Washington, DC.
8. R.E. Shore, M.J. Gardner, B. Pannett, Ethylene oxide: an assessment of the epidemiological evidence on carcinogenicity, Br. J. Ind. Med. 50 (1993) 971-997.
9. J. Mayer, D. Warburton, A.M. Jeffrey, R. Pero, S. Walles, L. Andrews, M. Toor, L. Latriano, L. Wazneh, D. Tang, W.-Y. Tsai, M. Kuroda, F. Perera, Biologic markers in ethylene oxide-exposed workers and controls, Mutation Res. 248 (1991) 163-176.
10. A.D. Tates, T. Grummt, M. Törnqvist, P.B. Farmer, F.J. van Dam, H. van Mossel, H.M. Schoemaker, S. Osterman-Golkar, Ch. Uebel, Y.S. Tang, A.H. Zwinderman, A.T. Natarajan, L. Ehrenberg, Biological and chemical monitoring of occupational exposure to ethylene oxide, Mutation Res. 250 (1991) 483-497.
11. P.A. Schulte, M. Boeniger, J.T. Walker, S.E. Schober, M.A. Pereira, D.K. Gulati, J.P. Wojciechowski, A. Garza, R. Froelich, G. Strauss, W.E. Halperin, R. Herrick, J. Griffith, Biologic markers in hospital workers exposed to low levels of ethylene oxide, Mutation Res. 278 (1992) 237-251.
12. D. Lerda, R. Rizzi, Cytogenetic study of persons occupationally exposed to ethylene oxide, Mutation Res. 281 (1992) 31-37.
13. E.C. Miller, J.A. Miller, Mechanisms of chemical carcinogenesis: nature of proximate carcinogens and interactions with macromolecules, Pharmacol. Rev. 18 (1966) 805-838.
14. V.E. Walker, T.R. Skopek, A mouse model for the study of in vivo mutational spectra: Sequence specificity of ethylene oxide at the hprt locus, Mutation Res. 288 (1993) 151-162.
15. D. Segerbäck, Reaction products in hemoglobin and DNA after in vitro treatment with ethylene oxide and N-(2-hydroxyethyl)-N-nitrosourea, Carcinogenesis 11 (1990) 307-312.
16. F. Li, A. Segal, J.J. Solomon, In vitro reaction of ethylene oxide with DNA and characterization of DNA adducts, Chem.-Biol. Interact. 83 (1992) 35-54.
17. S. Osterman-Golkar, P.B. Farmer, D. Segerbäck, E. Bailey, C.J. Calleman, K. Svensson, L. Ehrenberg, Dosimetry of ethylene oxide in the rat by quantitation of alkylated histidine in hemoglobin, Teratogen. Carcinogen. Mutagen. 3 (1983) 395-405.
18. D. Segerbäck, Alkylation of DNA and haemoglobin in the mouse following exposure to ethane and ethene oxide, Chem.-Biol. Interact. 45 (1993) 139-151.
19. V.E. Walker, T.R. Fennell, P.B. Upton, T.R. Skopek, V. Prevost, D.E.G. Shuker, J.A. Swenberg, Molecular dosimetry of ethylene oxide: formation and persistence of 7-(2-hydroxyethyl)guanine in DNA following repeated exposures of rats and mice, Cancer Res. 52 (1992) 4328-4334.
20. C.D. Brown, J.P. MacNeela, B. Wong, T.R. Fennell, DNA and hemoglobin adduct dosimetry in normal and transgenic mice exposed to ethylene oxide, Proc. Am. Assoc. Cancer Res. 35 (1994) 95.
21. V.E. Walker, T.R. Fennell, P.B. Upton, J.P. MacNeela, J.A. Swenberg, Molecular dosimetry of DNA and hemoglobin adducts in mice and rats exposed to ethylene oxide, Environ. Health Persp. 99 (1993) 11-17.
22. A. Kolman, T. Bohušová, B. Lambert, J.W.I.M. Simons, Induction of 6-thioguanine-resistant mutants in human diploid fibroblasts in vitro with ethylene oxide, Environ. Mol. Mutagen. 19 (1992) 93-97.
23. T. Bastlová, B. Andersson, B. Lambert, A. Kolman, Molecular analysis of ethylene oxide-induced mutations at the HPRT locus in human diploid fibroblasts, Mutation Res. 287 (1993) 283-292.
24. J.E. Cochrane, T.R. Skopek, Mutagenicity of butadiene and its epoxide metabolites: II. Mutational spectra of butadiene, 1,2-epoxybutene and diepoxybutane at the hprt locus in splenic T cells from exposed B6C3F1 mice, Carcinogenesis 15 (1994) 719-723.
25. Walker, V.E., N.J. Gorelick, J.A. Andrews, T.R Craft, J. deBoer, B.W. Glickman and T.R. Skopek (1996) Frequency and spectrum of ethylnitrosourea induced mutation at the hprt and lacI loci in splenic T-cells of exposed lacI transgenic mice, Cancer Res., in press.
26. Meng, Q., L. Recio, B.A. Wong, A. Reilly and V.E. Walker (1996) Comparison of the mutagenic potency of 1,3-butadiene at the hprt locus of T-cells following inhalation exposures of B6C3F1 mice and F344 rats, Carcinogenesis, submitted.
27. V.E. Walker, I.M. Jones, J. Nakamura, K. Burkhart-Schultz, T.R. Skopek, Age-dependent relationships between exposure and phenotypic expression of hprt mutations in T-cells from mice treated with N-ethyl-N-nitrosourea, Environ. Mol. Mutagen. 21 (Suppl. 22) (1993) 75.
28. I.M. Jones, K. Burkhart-Schultz, C.L. Strout, T.L. Crippen, Factors that affect the frequency of thioguanine-resistant lymphocytes in mice following exposure to ethylnitrosourea, Environ. Mutagen. 9 (1987) 317-329.
29. B.A. Smith, N.F. Fullerton, R.H. Heflich, F.A. Beland, DNA adduct formation and T-lymphocyte mutation induction in F344 rats implanted with tumorigenic doses of 1,6-dinitropyrene, Cancer Res. 55 (1995) 2316-2324.
30. Swenberg, J.A., Fedtke, N., Fennell, T.R. and Walker, V.E. (1990) Relationships between carcinogen exposure, DNA adducts and carcinogenesis, in: D.B. Clayson, I.C. Munro, P. Shubik and J.A. Swenberg (Eds.), Progress in Predictive Toxicology, Elsevier, Amsterdam, pp. 161-184.
31. V.E. Walker, T.R. Craft, T.R. Skopek, Spectrum of ethylene oxide induced mutation in hprt exon 3 of splenic T-cells from exposed B6C3F1 mice, Environ. Mol. Mutagen. 23 (Suppl. 23) (1994) 72.
32. K.S. Tao, C. Urlando, J.A. Heddle, Comparison of somatic mutation in a transgenic versus host locus, Proc. Natl. Acad. Sci. USA 90 (1993) 10681-10685.
33. R.A. Winegar, L.H. Lutze, J.D. Hamer, K.G. O'Loughlin, J.C. Miralis, Radiation-induced point mutations, deletions and micronuclei in lacI transgenic mice, Mutation Res. 307 (1994) 479-487.
34. N.J. Gorelick, Overview of mutation assays in transgenic mice for routine testing, Environ. Mol. Mutagen. 25 (1995) 218-230.
35. A. Kolman, M. Näslund, C.J. Calleman, Genotoxic effects of ethylene oxide and their relevance to human cancer, Carcinogenesis 7 (1986) 1245-1250.
36. E. Agurell, H. Cederberg, L. Ehrenberg, K. Lindahl-Kiessling, U. Rannug, M. Törnqvist, Genotoxic effects of ethylene oxide and propylene oxide: a comparative study, Mutation Res. 250 (1991) 229-237.
37. T.R. Skopek, Of mice and men: target size and sensitivity, Mutation Res. 331 (1995) 225-228.
38. T.R. Skopek, K.L. Kort, D.R. Marino, Relative sensitivity of the endogenous hprt gene and lacI transgene in ENU-treated Big Blue™ B6C3F1 mice, Environ. Mol. Mutagen. 26 (1995) 9-15.
39. Skopek, T.R., K.K. Kort, D.R. Marino, L.V. Mittal, D.R. Umbenhauer, G.M. Laws and S.P. Adams (1996) Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue® mice, Environ. Mol. Mutagen., submitted.
40. Walker, V.E., J.L. Andrews, P.B. Upton, J.G. deBoer and N.J. Gorelick (1996) Detection of cyclophosphamide-induced mutations at the hprt but not the lacI locus in splenic lymphocytes of exposed mice, Cancer Res., submitted.